CMXHF:OTCMKTS
CSL Ltd
121,10 $
0,00%
(0,00) 1D
9. okt., 12:22:41 GMT -4 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za CMXHF …
Tržna kapitalizacija
89,69 mrd.
Povprečni promet
167,00
Promet
0,00
52-tedenski najvišji tečaj
148,36 $
52-tedenski najnižji tečaj
63,84 $
Beta
0,56
Št. izdanih delnic
479,88 mio.
Št. zaposlenih
29 tis.
Tržna kapitalizacija
89,69 mrd.
Povprečni promet
167,00
Promet
0,00
52-tedenski najvišji tečaj
148,36 $
52-tedenski najnižji tečaj
63,84 $
Beta
0,56
Št. izdanih delnic
479,88 mio.
Št. zaposlenih
29 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
ad-hoc-news.de
·
pred 4 urami
CSL agrees Alentis drug deal as CSL stock has AUD 89.7 billion value
ad-hoc-news.de
·
pred 2 dnevoma
CSL sets October 27 AGM in Melbourne for CSL stock
ad-hoc-news.de
·
pred 3 dnevi
CSL stock trades at EUR 114.24 with AUD 88.5 billion market cap
ad-hoc-news.de
·
pred 3 dnevi
CSL signs rare-disease deal and CSL stock costs EUR 114.58
Profil
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Vizitka: CSL Ltd
Generalni direktorPaul McKenzie
Št. zaposlenih29 tis.
Ustanovljeno1916
SedežMelbourne, Viktorija, Avstralija
Sektor-
Spletno mestocsl.com